Skip to main content
OpenTrials
Completed

NCT Number: NCT04181242

Epidemiology of Injuries in Elite Badminton Players: a Prospective Study

Objective: To determine the incidence and characteristics of injuries in elite badminton players over a competitive season.

Design: 12-months prospective cohort study Setting: The French National Institute of Sport, Expertise, and Performance (INSEP).

Participants: Twenty international elite badminton players Independent variables: The type, the location, the occurrence of the injury (match or training), the footwork type, the type of shot and the perceived fatigue were collected.

Main Outcome Measures: Injury incidence rates were calculated per 1000 hours of play (Hop).

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

CHU Caen Normandie

Caen, 14000, France

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Badminton players training at the at the French National Institute of Sport, Expertise, and Performance (INSEP)
  • Participant competing at an international level
  • Medical follow-up over the 12-months duration of the study

Exclusion criteria

  • Participant unable to speak and read French language
  • Participant under the age of 18
  • Lack of informed and signed consent

Treatment and study plan

Primary outcomes

  1. Injury incidence rates

    Time frame: Injury incidence rates were calculated per 1000 hours of play (Hop) over the 12-month prospective follow-up

    Injury incidence rates were calculated per 1000 hours of play (Hop).

Secondary outcomes

  1. Injury incidence rates according to gender

    Time frame: Injury incidence rates were calculated per 1000 hours of play (Hop) over the 12-month prospective follow-up

    Injury incidence rates were calculated per 1000 hours of play (Hop) in male and female

  2. Injury incidence rates according to discipline

    Time frame: Injury incidence rates were calculated per 1000 hours of play (Hop) over the 12-month prospective follow-up

    Injury incidence rates were calculated per 1000 hours of play (Hop) in singles and doubles players

  3. Injury incidence rates according to occurence

    Time frame: Injury incidence rates were calculated per 1000 hours of play (Hop) over the 12-month prospective follow-up

    Injury incidence rates were calculated per 1000 hours of play (Hop) in match or training

  4. Description of injuries according to location (on the body, n)

    Time frame: Description of the number of injuries according to location of the injury on the body (n) over the 12-month prospective follow-up

    Number of injuries according to location of the injury (on the body, n)

  5. Description of injuries according to type of the injury (n)

    Time frame: Description of injuries according to the type of the injury (structure: muscle, tendon, bone, nerve...) (n) over the 12-month prospective follow-up

    Number of injuries according to type of the injury (n)

  6. Description of injuries according to location (on the body, % of all)

    Time frame: Description of the distribution of injuries according to location of the injury on the body (%) over the 12-month prospective follow-up

    Distribution of injuries according to location of the injury (on the body, % of all)

  7. Description of injuries according to type of the injury (% of all)

    Time frame: Description of the distribution of injuries according to the type of the injury (structure: muscle, tendon, bone, nerve...) (%) over the 12-month prospective follow-up

    Distribution of injuries according to type of the injury (% of all)

Sponsors and collaborators

Lead sponsor

University Hospital, Caen

Other

Registry information

Acronym: BADINSEP

Important dates

Study start
2016
Primary completion
2016
Study completion
2018
First posted
Nov 29, 2019
Registry last updated
Mar 26, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.